Targeting RNS/caveolin-l/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery

• 来源期刊: 中国药理学报（英文版）
• 关键词: Ischemic stroke caveolin-l reactive nitrogen species (RNS) MMPs natural compound
• 年，卷（期）: 2018,（5）
• 页码范围: 669-682
• 页数: 14页
• 语种: 英文
• DOI: 10.1038/aps.2018.27

摘要

Reactive nitrogen species (RNS) play important roles in mediating cerebral ischemia-reperfusion injury. RNS activate multiple signaling pathways and participate in different cellular events in cerebral ischemia-reperfusion injury. Recent studies have indicated that caveolin-l and matrix metalloproteinase (MMP) are important signaling molecules in the pathological process of ischemic brain injury. During cerebral ischemia-reperfusion, the production of nitric oxide (NO) and peroxynitrite (ONOO ), two representative RNS, down-regulates the expression of caveolin-l (Cav-1) and, in turn, further activates nitric oxide synthase (NOS) to promote RNS generation. The increased RNS further induce MMP activation and mediate disruption of the blood-brain barrier (BBB), aggravating the brain damage in cerebral ischemia-reperfusion injury. Therefore, the feedback interaction among RNS/Cav-l/MMPs provides an amplified mechanism for aggravating ischemic brain damage during cerebral ischemia-reperfusion injury. Targeting the RNS/Cav-1/ MMP pathway could be a promising therapeutic strategy for protecting against cerebral ischemia-reperfusion injury. In this mini-review article, we highlight the important role of the RNS/Cav-l/MMP signaling cascades in ischemic stroke injury and review the current progress of studies seeking therapeutic compounds targeting the RNS/Cav-l/MMP signaling cascades to attenuate cerebral ischemia- reperfusion injury. Several representative natural compounds, including calycosin-7-O-β-D-glucoside,baicalin,Momordica charantia polysaccharide (MCP), chlorogenic acid, lutein and lycopene, have shown potential for targeting the RNS/Cav-l/MMP signaling pathway to protect the brain in ischemic stroke. Therefore, the RNS/Cav-l/MMP pathway is an important therapeutic target in ischemic stroke treatment.